Statins are still very cheap and highly effective cholesterol-lowering drugs, they like to say, but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, according to findings published Sunday in Mayo Clinic Proceedings.
What they do not say is that the chemical combo increases the risk of adverse drug interactions, and thus, side effects are probably multiplied. But what they do say is that this combination therapy would prevent more than 330,000 deaths a year worldwide among patients who have already suffered a heart attack, including almost 50,000 deaths in the U.S. alone, researchers said.
“This study confirms that combined cholesterol lowering therapy should be considered immediately and should be the gold standard for treatment of very high-risk patients after an acute cardiovascular event,” senior researcher Dr. Peter Toth, a professor of clinical family and community medicine at the University of Illinois, said in a news release.
I do not believe a word of it.
Not when the so-called “evidence” is brought to us by pharmaceutical insiders, echoed by compromised journals, and spoon-fed to the public through press releases designed to scare and sell. The idea that combining statins with another drug like ezetimibe — both known to cause adverse effects — will now become the “gold standard” for saving lives is not only scientifically dishonest, it’s medically reckless.
Let’s be clear: Statins do not treat the root cause of heart disease. They merely manipulate a number — cholesterol — that’s been scapegoated for decades. As I’ve written before, cholesterol is not the enemy. It is essential, even protective, especially during physiological stress or inflammation. The real villain isn’t cholesterol — it’s inflammation. It’s oxidative stress. It’s magnesium deficiency. It’s acidic tissue environments.
What’s worse, this “gold standard” of dual-drug therapy does nothing to address the cause of cardiovascular disease—it merely numbs the metrics while the fire burns on beneath the surface. Statins and ezetimibe do not touch the deeper pathology. They do not reduce arterial stiffness, restore endothelial function, or regenerate heart tissue. They suppress, silence, mask, and damage.
This system is built on lies so deeply embedded in medical culture that even “confessions of a cardiologist,” as I once highlighted, are not enough to turn the tide. They know it’s inflammation. They know it’s about the terrain. Yet they keep prescribing drugs that damage the liver, drain CoQ10, suppress cognition, and provoke muscular degeneration.
They are crazy because they dare to call this progress.
Meanwhile, in the natural world, solutions abound — and they don’t require prescriptions. They require understanding. Bicarbonate therapy, magnesium repletion, vitamin D restoration, high-dose omega-3s, infrared therapy, and breathing techniques that regulate CO₂ and oxygen balance. These are the actual “gold standard” therapies. And unlike statins, they don’t cause side effects — they create side benefits.
If we are going to stop heart disease — truly stop it — we must abandon this cholesterol-lowering myth once and for all. The body isn’t betraying us. It’s doing its best under toxic, nutrient-depleted, pharmaceutically hijacked conditions. The betrayal is not in your arteries. It’s in the medical-industrial complex. It’s in the pills sold as salvation while the cause is ignored.
Medical truth is oxygen for heart and vascular patients. Hearts are worth saving; that is what modern cardiology is supposed to be all about. However, the death rate from cardiovascular disease is off the charts, bringing sudden death or cerebral degeneration to uncounted millions.
In my work on cardiovascular healing, I’ve long emphasized that cholesterol is not the cause. It’s a response. It’s like the firefighter at the fire scene — and the statin industry is busy shooting the firefighter while the flames rage on. What’s burning the house down is inflammation, oxidative damage, calcium dysregulation, and — at the very root — magnesium deficiency.
Magnesium is the guardian mineral of the heart. It calms the nervous system, prevents arterial calcification, improves mitochondrial function, and facilitates over 600 enzymatic processes. But it doesn’t work alone. One of our time’s most exciting medical combinations is emerging not from billion-dollar pharmaceutical pipelines but from intelligent synergy: Cyclodextrin and Magnesium. This pair is what I now call the Batman and Robin of cardiovascular regeneration.
Cyclodextrins—unique ring-shaped molecules—have the uncanny ability to encapsulate and extract cholesterol crystals, toxins, and inflammatory debris from arterial walls without harming the structural integrity of the tissues. But their true superpower? Creating space—making room for healing. And when that space is opened, magnesium rushes in like a master mechanic, recharging the cells, calming the terrain, and rebooting life from the inside out.
Unlike statins, which paralyze a protective function, Batman and Robin mobilize your body’s true intelligence. They don’t suppress symptoms — they restore coherence. They don’t generate side effects — they generate life. Imagine if we shifted the standard of care from suppression to regeneration. From cholesterol obsession to inflammation resolution.
That is the revolution we are introducing with our new book on natural cardiovascular medicine:

So yes, go ahead and stack your statins with ezetimibe — if your goal is to keep dying slowly. But if you want to reverse heart disease, reclaim your energy, and heal your heart from the inside out, look elsewhere.
Look to magnesium and bicarbonate, cyclodextrins and CO₂, oxygen, hydrogen, and other things that make up a potent protocol. Batman and Robin have arrived. And they don’t wear lab coats. They restore flow. They clear space. They turn the lights back on. And that, not another cholesterol-lowering pill, is how you save a heart.
comments